AAAAAA

   
Results: 1-9 |
Results: 9
P66 P51 AND P51/P51 RECOMBINANT FORMS OF REVERSE-TRANSCRIPTASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - INTERACTIONS WITH PRIMER TRNA(LYS3), INITIATION OF CDNA SYNTHESIS, AND EFFECT OF INHIBITORS/
Authors: DUFOUR E ELDIRANIDIAB R BOULME F FOURNIER M NEVINSKY G TARRAGOLITVAK L LITVAK S ANDREOLA ML
Citation: E. Dufour et al., P66 P51 AND P51/P51 RECOMBINANT FORMS OF REVERSE-TRANSCRIPTASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - INTERACTIONS WITH PRIMER TRNA(LYS3), INITIATION OF CDNA SYNTHESIS, AND EFFECT OF INHIBITORS/, European journal of biochemistry, 251(1-2), 1998, pp. 487-495
STRUCTURAL CONSTRAINTS IN THE HIV-1 REVERSE TRANCRIPTASE-PRIMER TEMPLATE COMPLEX FOR THE INITIATION OF DNA-SYNTHESIS FROM PRIMER TRNA(LYS3)/
Authors: ZAKHAROVA OD MARTIYANOV IV TIMOFEEVA OA KOLOCHEVA TI FOURNIER M ANDREOLA ML MAKSAKOVA GA YAMKOVOY VI LITVAK S TARRAGOLITVAK L NEVINSKY GA
Citation: Od. Zakharova et al., STRUCTURAL CONSTRAINTS IN THE HIV-1 REVERSE TRANCRIPTASE-PRIMER TEMPLATE COMPLEX FOR THE INITIATION OF DNA-SYNTHESIS FROM PRIMER TRNA(LYS3)/, Biochemistry, 37(38), 1998, pp. 13343-13348
NOVEL C-ORGANOSILICON DERIVATIVES AS LEADS FOR REVERSE-TRANSCRIPTASE-MEDIATED ANTI-HIV-1 ACTIVITY
Authors: DELORD B GUILLORIT MC LAFAY J ANDREOLA ML THARAUD D TARRAGOLITVAK L FLEURY HJA DELERIS G
Citation: B. Delord et al., NOVEL C-ORGANOSILICON DERIVATIVES AS LEADS FOR REVERSE-TRANSCRIPTASE-MEDIATED ANTI-HIV-1 ACTIVITY, European journal of medicinal chemistry, 31(2), 1996, pp. 111-122
INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE WITH PRIMER TRNA(LYS3) AND AFFINITY MODIFICATION OF THE ENZYME BY TRNA(LYS3) DERIVATIVES
Authors: NEVINSKY GA ZAKHAROVA OD FOURNIER M ANDREOLA ML LITVAK S TARRAGOLITVAK L
Citation: Ga. Nevinsky et al., INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE WITH PRIMER TRNA(LYS3) AND AFFINITY MODIFICATION OF THE ENZYME BY TRNA(LYS3) DERIVATIVES, European journal of biochemistry, 240(3), 1996, pp. 774-780
A NEW SERIES OF PYRIDINONE DERIVATIVES AS POTENT NONNUCLEOSIDE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
Authors: DOLLE V FAN E NGUYEN CH AUBERTIN AM KIRN A ANDREOLA ML JAMIESON G TARRAGOLITVAK L BISAGNI E
Citation: V. Dolle et al., A NEW SERIES OF PYRIDINONE DERIVATIVES AS POTENT NONNUCLEOSIDE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS, Journal of medicinal chemistry, 38(23), 1995, pp. 4679-4686
INTERACTION OF PRIMER TRNA(LYS3) WITH THE P51 SUBUNIT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - A POSSIBLE ROLE IN ENZYME ACTIVATION
Authors: ZAKHAROVA OD TARRAGOLITVAK L FOURNIER M ANDREOLA ML REPKOVA MN VENYAMINOVA AG LITVAK S NEVINSKY GA
Citation: Od. Zakharova et al., INTERACTION OF PRIMER TRNA(LYS3) WITH THE P51 SUBUNIT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - A POSSIBLE ROLE IN ENZYME ACTIVATION, FEBS letters, 361(2-3), 1995, pp. 287-290
HIGH-AFFINITY INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE WITH PARTIALLY COMPLEMENTARY PRIMERS
Authors: ZAKHAROVA OD TARRAGOLITVAK L MAKSAKOVA G ANDREOLA ML DUFOUR E LITVAK S NEVINSKY GA
Citation: Od. Zakharova et al., HIGH-AFFINITY INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE WITH PARTIALLY COMPLEMENTARY PRIMERS, European journal of biochemistry, 233(3), 1995, pp. 856-863
THE REVERSE-TRANSCRIPTASE OF HIV-1 - FROM ENZYMOLOGY TO THERAPEUTIC INTERVENTION
Authors: TARRAGOLITVAK L ANDREOLA ML NEVINSKY GA SARIHCOTTIN L LITVAK S
Citation: L. Tarragolitvak et al., THE REVERSE-TRANSCRIPTASE OF HIV-1 - FROM ENZYMOLOGY TO THERAPEUTIC INTERVENTION, The FASEB journal, 8(8), 1994, pp. 497-503
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE COPIES VERYSHORT TEMPLATES - KINETIC AND CROSS-LINKING ANALYSIS
Authors: ANDREOLA ML DUFOUR E TARRAGOLITVAK L JAMKOVOY VI LEVINA AS BARR PJ LITVAK S NEVINSKY GA
Citation: Ml. Andreola et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE COPIES VERYSHORT TEMPLATES - KINETIC AND CROSS-LINKING ANALYSIS, Biochimica et biophysica acta, 1173(2), 1993, pp. 147-154
Risultati: 1-9 |